Farallon Capital Management LLC Beam Therapeutics Inc. Transaction History
Farallon Capital Management LLC
- $20.7 Billion
- Q2 2024
A detailed history of Farallon Capital Management LLC transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Farallon Capital Management LLC holds 7,913,123 shares of BEAM stock, worth $175 Million. This represents 0.9% of its overall portfolio holdings.
Number of Shares
7,913,123Holding current value
$175 Million% of portfolio
0.9%Shares
15 transactions
Others Institutions Holding BEAM
# of Institutions
230Shares Held
71.8MCall Options Held
283KPut Options Held
233K-
Vanguard Group Inc Valley Forge, PA7.9MShares$175 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.63MShares$169 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.63MShares$169 Million1.63% of portfolio
-
Arch Venture Management, LLC Chicago, IL5.44MShares$121 Million74.72% of portfolio
-
State Street Corp Boston, MA3.49MShares$77.4 Million0.0% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $1.56B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...